Algernon Pharmaceuticals (CSE: AGN) Launches $1M Private Placement Offering with Equity and Warrants Structure
Algernon Pharmaceuticals Inc., a Canadian clinical-stage drug development firm, has announced a non-brokered private placement aimed at raising gross proceeds of $1,000,000. The Offering will be divided equally between Common Units, priced at $0.07 per unit, and Preferred Units, priced at $0.70 per unit. …
Team Kalkine |
27 May 2025| Read Time : 10 Mins